Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.

Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M.

Breast Cancer Res. 2008;10(4):R57. doi: 10.1186/bcr2114.

2.

Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer.

Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K.

Breast Cancer Res. 2001;3(4):264-9.

3.

A variant (rs932335) in the HSD11B1 gene is associated with colorectal cancer in a Chinese population.

Wang J, Gao Y, Wang L, Liu X, Li J, Wang Z, Zhou J, Wang K.

Eur J Cancer Prev. 2013 Nov;22(6):523-8. doi: 10.1097/CEJ.0b013e3283656346.

PMID:
24061267
4.

Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Dossus L, McKay JD, Canzian F, Wilkening S, Rinaldi S, Biessy C, Olsen A, Tjønneland A, Jakobsen MU, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Fournier A, Linseisen J, Lukanova A, Boeing H, Fisher E, Trichopoulou A, Georgila C, Trichopoulos D, Palli D, Krogh V, Tumino R, Vineis P, Quirós JR, Sala N, Martínez-García C, Dorronsoro M, Chirlaque MD, Barricarte A, van Duijnhoven FJ, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Hallmans G, Lenner P, Bingham S, Khaw KT, Key TJ, Travis RC, Ferrari P, Jenab M, Riboli E, Kaaks R.

Carcinogenesis. 2008 Jul;29(7):1360-6. doi: 10.1093/carcin/bgn083.

PMID:
18375957
5.

The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer.

Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A.

Carcinogenesis. 2004 Dec;25(12):2473-8.

PMID:
15308584
6.

Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation.

Lautier C, El Mkadem SA, Renard E, Brun JF, Gris JC, Bringer J, Grigorescu F.

Hum Genet. 2003 Jul;113(1):34-43.

PMID:
12687350
7.

ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity.

Connor A, Baumgartner RN, Kerber RA, O'Brien E, Rai SN, Wolff RK, Slattery ML, Giuliano AR, Risendal BC, Byers TE, Baumgartner KB.

Cancer Causes Control. 2012 Oct;23(10):1653-63. doi: 10.1007/s10552-012-0043-6.

8.

Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian population?

Karimi K, Mahmoudi T, Karimi N, Dolatmoradi H, Arkani M, Farahani H, Vahedi M, Parsimehr E, Dabiri R, Nobakht H, Asadi A, Zali MR.

Asian Pac J Cancer Prev. 2013;14(9):5011-6.

9.

Haplotypes of the estrogen receptor beta gene and breast cancer risk.

Breast and Prostate Cancer Cohort Consortium., Cox DG, Bretsky P, Kraft P, Pharoah P, Albanes D, Altshuler D, Amiano P, Berglund G, Boeing H, Buring J, Burtt N, Calle EE, Canzian F, Chanock S, Clavel-Chapelon F, Colditz GA, Feigelson HS, Haiman CA, Hankinson SE, Hirschhorn J, Henderson BE, Hoover R, Hunter DJ, Kaaks R, Kolonel L, LeMarchand L, Lund E, Palli D, Peeters PH, Pike MC, Riboli E, Stram DO, Thun M, Tjonneland A, Travis RC, Trichopoulos D, Yeager M.

Int J Cancer. 2008 Jan 15;122(2):387-92.

10.

Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.

Szendrei B, González-Lamuño D, Amigo T, Wang G, Pitsiladis Y, Benito PJ, Gomez-Candela C, Calderón FJ, Cupeiro R; PRONAF Study Group..

Appl Physiol Nutr Metab. 2016 Mar;41(3):307-14. doi: 10.1139/apnm-2015-0425.

PMID:
26888112
11.

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Chen YC, Kraft P, Bretsky P, Ketkar S, Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H, Burtt N, Bueno-de-Mesquita B, Cann H, Canzian F, Chanock S, Dunning A, Feigelson HS, Freedman M, Gaziano JM, Giovannucci E, Sánchez MJ, Haiman CA, Hallmans G, Hayes RB, Henderson BE, Hirschhorn J, Kaaks R, Key TJ, Kolonel LN, LeMarchand L, Ma J, Overvad K, Palli D, Pharaoh P, Pike M, Riboli E, Rodriguez C, Setiawan VW, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Virtamo J, Trichopoulou A, Wacholder S, Weinstein SJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1973-81.

12.

A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations.

Naka I, Hikami K, Nakayama K, Koga M, Nishida N, Kimura R, Furusawa T, Natsuhara K, Yamauchi T, Nakazawa M, Ataka Y, Ishida T, Inaoka T, Iwamoto S, Matsumura Y, Ohtsuka R, Tsuchiya N, Ohashi J.

Int J Obes (Lond). 2013 Sep;37(9):1204-10. doi: 10.1038/ijo.2012.206.

13.

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

BMC Med Genet. 2007 Dec 1;8:72.

14.

Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.

BMC Cancer. 2005 Jul 19;5:81.

15.

A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.

Olza J, Gil-Campos M, Leis R, Rupérez AI, Tojo R, Cañete R, Gil A, Aguilera CM.

Int J Obes (Lond). 2012 Dec;36(12):1558-63. doi: 10.1038/ijo.2012.4.

PMID:
22310475
16.

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.

Lee E, Schumacher F, Lewinger JP, Neuhausen SL, Anton-Culver H, Horn-Ross PL, Henderson KD, Ziogas A, Van Den Berg D, Bernstein L, Ursin G.

Breast Cancer Res. 2011 Apr 1;13(2):R37. doi: 10.1186/bcr2859.

17.

The ADRB3 Trp64Arg variant and obesity in African-American breast cancer cases.

McKean-Cowdin R, Li X, Bernstein L, McTiernan A, Ballard-Barbash R, Gauderman WJ, Gilliland F.

Int J Obes (Lond). 2007 Jul;31(7):1110-8.

18.

Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.

Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1206-14.

19.

Genetic polymorphisms of beta2- and beta3-adrenergic receptor genes associated with characteristics of the metabolic syndrome in black South African women.

Rooyen JM, Pretorius PJ, Britz M, Huisman HW, Schutte AE, Towers GW, Olckers A, Schwarz PE, Malan NT, Malan L, Schutte R.

Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):236-40. doi: 10.1055/s-2007-992785.

PMID:
18393130
20.

Gly972Arg variant of insulin receptor substrate 1 gene and colorectal cancer risk in overweight/obese subjects.

Mahmoudi T, Majidzadeh-A K, Karimi K, Farahani H, Dabiri R, Nobakht H, Asadi A, Karimi N, Arkani M, Zali MR.

Int J Biol Markers. 2016 Feb 28;31(1):e68-72. doi: 10.5301/jbm.5000159.

PMID:
26349669

Supplemental Content

Support Center